AVALYN PHARMA
Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other severe respiratory diseases. Its therapies rapidly advance AP01 for the treatment of IPF, provides additional pipeline candidates for IPF, improve the care and outcomes of severe respiratory diseases, and develop novel inhaled therapeutics. Avalyn Pharma was established in 2011 and is headquartered in Seattle, Washington.
AVALYN PHARMA
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2011-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.avalynpharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
97.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Euro Microsoft Exchange Online
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Novo Holdings
Novo Holdings investment in Series B - Avalyn Pharma
Norwest Venture Partners
Norwest Venture Partners investment in Series B - Avalyn Pharma
RiverVest
RiverVest investment in Series B - Avalyn Pharma
TPG Biotech
TPG Biotech investment in Series B - Avalyn Pharma
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Avalyn Pharma
F-Prime Capital
F-Prime Capital investment in Series B - Avalyn Pharma
Edmond de Rothschild Private Equity
Edmond de Rothschild Private Equity investment in Series A - Avalyn Pharma
Andera Partners
Andera Partners investment in Series A - Avalyn Pharma
Novo Holdings
Novo Holdings investment in Series A - Avalyn Pharma
F-Prime Capital
F-Prime Capital investment in Series A - Avalyn Pharma
Official Site Inspections
http://www.avalynpharma.com
- Host name: 170.251.121.34.bc.googleusercontent.com
- IP address: 34.121.251.170
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
